Monday, December 23, 2024

Healthcare

NurExone gains traction in Europe with Orphan drug designation awarded by regulator (TSXV: NRX) (FSE: J90) (NRX.V)

NurExone Biologic Inc. is a TSXV-listed pharmaceutical company that is developing a platform for biologically-guided ExoTherapy to be delivered, non-invasively, to patients who suffer...

NurExone Biologic Inc. is Poised to Capture Significant Value (TSXV: NRX) (FSE: J90) (NRX.V)

Unfortunately, war is the daily media lead. We get the numbers of dead and injured for each conflict. You might consider those just injured...

Undervalued Israeli Biotech : NurExone Biologic Inc (TSXV: NRX)

 NurExone Biologic Inc’s (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone") mission is to pioneer the development of novel, biological, and minimally invasive treatment...

Predictmedix AI: Cuttiing Edge Health AI Technology for Better Emergency Triage (CSE:PMED, OTCQB:PMEDF, FRA:3QP)

PredictMedix AI (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) is an emerging provider of rapid health screening and remote patient care solutions globally—the Company's Safe Entry Stations...

The Analyst Report – Predictmedix AI: Unlocking Potential Growth And Strategies For Success (CSE: PMED) (OTC: PMEDF) (FRA: 3QP)

To truly understand and appreciate the growth potential of Predictmedix AI (CSE: PMED) (USOTC: PMEDF) (FRA: 3QP) it helps to understand how technologies like...

Popular

Subscribe